| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
| Sales | 1,360 | 820 | 0 | 0 | 0 |
| Sales Growth | +65.85% | unch | unch | unch | unch |
| Net Income | -11,130 | -9,910 | 3,690 | -8,530 | -8,830 |
| Net Income Growth | -12.31% | -368.56% | +143.26% | +3.40% | +55.61% |
Cannapharmarx Inc (CPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
CannaPharmaRX, Inc. is a pharmaceutical company. The company is engaged in cannabinoid discovery, science, research & development. Cannapharmarx Inc., formerly known as Golden Dragon Holding Co., is based in Carneys Point, New Jersey.
Fiscal Year End Date: 12/31